» Articles » PMID: 27373337

Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2016 Jul 5
PMID 27373337
Citations 624
Authors
Affiliations
Soon will be listed here.
Abstract

N(6)-methyladenosine (m(6)A) is a prevalent, reversible chemical modification of functional RNAs and is important for central events in biology. The core m(6)A writers are Mettl3 and Mettl14, which both contain methyltransferase domains. How Mettl3 and Mettl14 cooperate to catalyze methylation of adenosines has remained elusive. We present crystal structures of the complex of Mettl3/Mettl14 methyltransferase domains in apo form as well as with bound S-adenosylmethionine (SAM) or S-adenosylhomocysteine (SAH) in the catalytic site. We determine that the heterodimeric complex of methyltransferase domains, combined with CCCH motifs, constitutes the minimally required regions for creating m(6)A modifications in vitro. We also show that Mettl3 is the catalytically active subunit, while Mettl14 plays a structural role critical for substrate recognition. Our model provides a molecular explanation for why certain mutations of Mettl3 and Mettl14 lead to impaired function of the methyltransferase complex.

Citing Articles

The role of mA modification during macrophage metabolic reprogramming in human diseases and animal models.

Wang H, Xu P, Yin K, Wang S Front Immunol. 2025; 16:1521196.

PMID: 40066451 PMC: 11891544. DOI: 10.3389/fimmu.2025.1521196.


RNA Modification in Metabolism.

Liu Y, Sun Z, Gui D, Zhao Y, Xu Y MedComm (2020). 2025; 6(3):e70135.

PMID: 40066222 PMC: 11892166. DOI: 10.1002/mco2.70135.


Exon junction complexes regulate osteoclast-induced bone resorption by influencing the NFATc1 m6A distribution through the "shield effect".

Sun B, Yang J, Wang Z, Wang Z, Feng W, Li X Clin Transl Med. 2025; 15(3):e70266.

PMID: 40051055 PMC: 11885169. DOI: 10.1002/ctm2.70266.


The Emerging Role of m6A and Programmed Cell Death in Cardiovascular Diseases.

Wang H, Han J, Kong H, Ma C, Zhang X Biomolecules. 2025; 15(2).

PMID: 40001550 PMC: 11853213. DOI: 10.3390/biom15020247.


M6A methyltransferase METTL3 promotes glucose metabolism hub gene expression and induces metabolic dysfunction-associated steatotic liver disease (MASLD).

Wang S, Xu Z, Wang Z, Yi X, Wu J BMC Genomics. 2025; 26(1):188.

PMID: 39994526 PMC: 11853331. DOI: 10.1186/s12864-025-11377-4.


References
1.
Wang X, Zhao B, Roundtree I, Lu Z, Han D, Ma H . N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency. Cell. 2015; 161(6):1388-99. PMC: 4825696. DOI: 10.1016/j.cell.2015.05.014. View

2.
Forbes S, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H . COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res. 2014; 43(Database issue):D805-11. PMC: 4383913. DOI: 10.1093/nar/gku1075. View

3.
Bell D . Novel genetic targets in endometrial cancer. Expert Opin Ther Targets. 2014; 18(7):725-30. PMC: 4128487. DOI: 10.1517/14728222.2014.909414. View

4.
Hall T . Multiple modes of RNA recognition by zinc finger proteins. Curr Opin Struct Biol. 2005; 15(3):367-73. DOI: 10.1016/j.sbi.2005.04.004. View

5.
Meyer K, Saletore Y, Zumbo P, Elemento O, Mason C, Jaffrey S . Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons. Cell. 2012; 149(7):1635-46. PMC: 3383396. DOI: 10.1016/j.cell.2012.05.003. View